Liver X receptors as potential targets for cancer therapeutics (Review)
- Authors:
- Xiaoli Ju
- Pan Huang
- Miao Chen
- Qiang Wang
-
Affiliations: Department of Pathology, School of Medicine, Jiangsu University, Zhenjiang, Jiangsu 212013, P.R. China, Institute of Life Sciences, Jiangsu University, Zhenjiang, Jiangsu 212013, P.R. China - Published online on: October 23, 2017 https://doi.org/10.3892/ol.2017.7259
- Pages: 7676-7680
This article is mentioned in:
Abstract
 |
|
Gronemeyer H, Gustafsson JA and Laudet V: Principles for modulation of the nuclear receptor superfamily. Nat Rev Drug Discov. 3:950–964. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Nuclear Receptors Nomenclature Committee, . A unified nomenclature system for the nuclear receptor superfamily. Cell. 97:161–163. 1999. View Article : Google Scholar : PubMed/NCBI | |
|
Evans RM and Mangelsdorf DJ: Nuclear receptors, RXR, and the big bang. Cell. 157:255–266. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Peet DJ, Turley SD, Ma W, Janowski BA, Lobaccaro JM, Hammer RE and Mangelsdorf DJ: Cholesterol and bile acid metabolism are impaired in mice lacking the nuclear oxysterol receptor LXR alpha. Cell. 93:693–704. 1998. View Article : Google Scholar : PubMed/NCBI | |
|
Apfel R, Benbrook D, Lernhardt E, Ortiz MA, Salbert G and Pfahl M: A novel orphan receptor specific for a subset of thyroid hormone-responsive elements and its interaction with the retinoid/thyroid hormone receptor subfamily. Mol Cell Biol. 14:7025–7035. 1994. View Article : Google Scholar : PubMed/NCBI | |
|
Willy PJ, Umesono K, Ong ES, Evans RM, Heyman RA and Mangelsdorf DJ: LXR, a nuclear receptor that defines a distinct retinoid response pathway. Genes Dev. 9:1033–1045. 1995. View Article : Google Scholar : PubMed/NCBI | |
|
Shinar DM, Endo N, Rutledge SJ, Vogel R, Rodan GA and Schmidt A: NER, a new member of the gene family encoding the human steroid hormone nuclear receptor. Gene. 147:273–276. 1994. View Article : Google Scholar : PubMed/NCBI | |
|
Wang Y, Rogers PM, Stayrook KR, Su C, Varga G, Shen Q, Nagpal S and Burris TP: The selective Alzheimer's disease indicator-1 gene (Seladin-1/DHCR24) is a liver X receptor target gene. Mol Pharmacol. 74:1716–1721. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Cha JY and Repa JJ: The liver X receptor (LXR) and hepatic lipogenesis. The carbohydrate-response element-binding protein is a target gene of LXR. J Biol Chem. 282:743–751. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Zelcer N and Tontonoz P: Liver X receptors as integrators of metabolic and inflammatory signaling. J Clin Invest. 116:607–614. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Viennois E, Pommier AJ, Mouzat K, Oumeddour A, El Hajjaji FZ, Dufour J, Caira F, Volle DH, Baron S and Lobaccaro JM: Targeting liver X receptors in human health: Deadlock or promising trail? Expert Opin Ther Targets. 15:219–232. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Viennois E, Mouzat K, Dufour J, Morel L, Lobaccaro JM and Baron S: Selective liver X receptor modulators (SLiMs): What use in human health? Mol Cell Endocrinol. 351:129–141. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Janowski BA, Willy PJ, Devi TR, Falck JR and Mangelsdorf DJ: An oxysterol signalling pathway mediated by the nuclear receptor LXR alpha. Nature. 383:728–731. 1996. View Article : Google Scholar : PubMed/NCBI | |
|
Janowski BA, Grogan MJ, Jones SA, Wisely GB, Kliewer SA, Corey EJ and Mangelsdorf DJ: Structural requirements of ligands for the oxysterol liver X receptors LXRalpha and LXRbeta. Proc Natl Acad Sci USA. 96:pp. 266–271. 1999; View Article : Google Scholar : PubMed/NCBI | |
|
Lehmann JM, Kliewer SA, Moore LB, Smith-Oliver TA, Oliver BB, Su JL, Sundseth SS, Winegar DA, Blanchard DE, Spencer TA and Willson TM: Activation of the nuclear receptor LXR by oxysterols defines a new hormone response pathway. J Biol Chem. 272:3137–3140. 1997. View Article : Google Scholar : PubMed/NCBI | |
|
Plat J, Nichols JA and Mensink RP: Plant sterols and stanols: Effects on mixed micellar composition and LXR (target gene) activation. J Lipid Res. 46:2468–2476. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Jayasuriya H, Herath KB, Ondeyka JG, Guan Z, Borris RP, Tiwari S, de Jong W, Chavez F, Moss J, Stevenson DW, et al: Diterpenoid, steroid, and triterpenoid agonists of liver X receptors from diversified terrestrial plants and marine sources. J Nat Prod. 68:1247–1252. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Schultz JR, Tu H, Luk A, Repa JJ, Medina JC, Li L, Schwendner S, Wang S, Thoolen M, Mangelsdorf DJ, et al: Role of LXRs in control of lipogenesis. Genes Dev. 14:2831–2838. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Houck KA, Borchert KM, Hepler CD, Thomas JS, Bramlett KS, Michael LF and Burris TP: T0901317 is a dual LXR/FXR agonist. Mol Genet Metab. 83:184–187. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Collins JL, Fivush AM, Watson MA, Galardi CM, Lewis MC, Moore LB, Parks DJ, Wilson JG, Tippin TK, Binz JG, et al: Identification of a nonsteroidal liver X receptor agonist through parallel array synthesis of tertiary amines. J Med Chem. 45:1963–1966. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Joseph SB, McKilligin E, Pei L, Watson MA, Collins AR, Laffitte BA, Chen M, Noh G, Goodman J, Hagger GN, et al: Synthetic LXR ligand inhibits the development of atherosclerosis in mice. Proc Natl Acad Sci USA. 99:pp. 7604–7609. 2002; View Article : Google Scholar : PubMed/NCBI | |
|
Kaneko E, Matsuda M, Yamada Y, Tachibana Y, Shimomura I and Makishima M: Induction of intestinal ATP-binding cassette transporters by a phytosterol-derived liver X receptor agonist. J Biol Chem. 278:36091–36098. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Quinet EM, Savio DA, Halpern AR, Chen L, Miller CP and Nambi P: Gene-selective modulation by a synthetic oxysterol ligand of the liver X receptor. J Lipid Res. 45:1929–1942. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Hu X, Li S, Wu J, Xia C and Lala DS: Liver X receptors interact with corepressors to regulate gene expression. Mol Endocrinol. 17:1019–1026. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Uno S, Endo K, Jeong Y, Kawana K, Miyachi H, Hashimoto Y and Makishima M: Suppression of beta-catenin signaling by liver X receptor ligands. Biochem Pharmacol. 77:186–195. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Derangère V, Chevriaux A, Courtaut F, Bruchard M, Berger H, Chalmin F, Causse SZ, Limagne E, Végran F, Ladoire S, et al: Liver X receptor β activation induces pyroptosis of human and murine colon cancer cells. Cell Death Differ. 21:1914–1924. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Courtaut F, Derangère V, Chevriaux A, Ladoire S, Cotte AK, Arnould L, Boidot R, Rialland M, Ghiringhelli F and Rébé C: Liver X receptor ligand cytotoxicity in colon cancer cells and not in normal colon epithelial cells depends on LXRβ subcellular localization. Oncotarget. 6:26651–26662. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Vedin LL, Gustafsson JA and Steffensen KR: The oxysterol receptors LXRα and LXRβ suppress proliferation in the colon. Mol Carcinog. 52:835–844. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Chuu CP: Modulation of liver X receptor signaling as a prevention and therapy for colon cancer. Med Hypotheses. 76:697–699. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Fukuchi J, Kokontis JM, Hiipakka RA, Chuu CP and Liao S: Antiproliferative effect of liver X receptor agonists on LNCaP human prostate cancer cells. Cancer Res. 64:7686–7689. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Pommier AJ, Alves G, Viennois E, Bernard S, Communal Y, Sion B, Marceau G, Damon C, Mouzat K, Caira F, et al: Liver X Receptor activation downregulates AKT survival signaling in lipid rafts and induces apoptosis of prostate cancer cells. Oncogene. 29:2712–2723. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Kim KH, Lee GY, Kim JI, Ham M, Won Lee J and Kim JB: Inhibitory effect of LXR activation on cell proliferation and cell cycle progression through lipogenic activity. J Lipid Res. 51:3425–3433. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Krycer JR and Brown AJ: Cross-talk between the androgen receptor and the liver X receptor: Implications for cholesterol homeostasis. J Biol Chem. 286:20637–20647. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Fu W, Yao J, Huang Y, Li Q, Li W, Chen Z, He F, Zhou Z and Yan J: LXR agonist regulates the carcinogenesis of PCa via the SOCS3 pathway. Cell Physiol Biochem. 33:195–204. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Gong H, Guo P, Zhai Y, Zhou J, Uppal H, Jarzynka MJ, Song WC, Cheng SY and Xie W: Estrogen deprivation and inhibition of breast cancer growth in vivo through activation of the orphan nuclear receptor liver X receptor. Mol Endocrinol. 21:1781–1790. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Vedin LL, Lewandowski SA, Parini P, Gustafsson JA and Steffensen KR: The oxysterol receptor LXR inhibits proliferation of human breast cancer cells. Carcinogenesis. 30:575–579. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Chuu CP and Lin HP: Antiproliferative effect of LXR agonists T0901317 and 22(R)-hydroxycholesterol on multiple human cancer cell lines. Anticancer Res. 30:3643–3648. 2010.PubMed/NCBI | |
|
El Roz A, Bard JM, Huvelin JM and Nazih H: LXR agonists and ABCG1-dependent cholesterol efflux in MCF-7 breast cancer cells: Relation to proliferation and apoptosis. Anticancer Res. 32:3007–3013. 2012.PubMed/NCBI | |
|
Nguyen-Vu T, Vedin LL, Liu K, Jonsson P, Lin JZ, Candelaria NR, Candelaria LP, Addanki S, Williams C, Gustafsson JÅ, et al: Liver × receptor ligands disrupt breast cancer cell proliferation through an E2F-mediated mechanism. Breast Cancer Res. 15:R512013. View Article : Google Scholar : PubMed/NCBI | |
|
Candelaria NR, Addanki S, Zheng J, Nguyen-Vu T, Karaboga H, Dey P, Gabbi C, Vedin LL, Liu K, Wu W, et al: Antiproliferative effects and mechanisms of liver X receptor ligands in pancreatic ductal adenocarcinoma cells. PLoS One. 9:e1062892014. View Article : Google Scholar : PubMed/NCBI | |
|
Wang F, Stappenbeck F, Matsui W and Parhami F: Inhibition of pancreatic cancer cell-induced paracrine hedgehog signaling by liver X receptor agonists and Oxy16, a naturally occurring oxysterol. J Cell Biochem. 118:499–509. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Joseph SB, Bradley MN, Castrillo A, Bruhn KW, Mak PA, Pei L, Hogenesch J, O'connell RM, Cheng G, Saez E, et al: LXR-dependent gene expression is important for macrophage survival and the innate immune response. Cell. 119:299–309. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Joseph SB, Castrillo A, Laffitte BA, Mangelsdorf DJ and Tontonoz P: Reciprocal regulation of inflammation and lipid metabolism by liver X receptors. Nat Med. 9:213–219. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
A-Gonzalez N, Bensinger SJ, Hong C, Beceiro S, Bradley MN, Zelcer N, Deniz J, Ramirez C, Díaz M, Gallardo G, et al: Apoptotic cells promote their own clearance and immune tolerance through activation of the nuclear receptor LXR. Immunity. 31:245–258. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Bensinger SJ, Bradley MN, Joseph SB, Zelcer N, Janssen EM, Hausner MA, Shih R, Parks JS, Edwards PA, Jamieson BD and Tontonoz P: LXR signaling couples sterol metabolism to proliferation in the acquired immune response. Cell. 134:97–111. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Wang Q, Ma X, Chen Y, Zhang L, Jiang M, Li X, Xiang R, Miao R, Hajjar DP, Duan Y and Han J: Identification of interferon-γ as a new molecular target of liver X receptor. Biochem J. 459:345–354. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Wang Q, Sun L, Yang X, Ma X, Li Q, Chen Y, Liu Y, Zhang D, Li X, Xiang R, et al: Activation of liver X receptor inhibits the development of pulmonary carcinomas induced by 3-methylcholanthrene and butylated hydroxytoluene in BALB/c mice. Sci Rep. 6:272952016. View Article : Google Scholar : PubMed/NCBI | |
|
Cui G, Qin X, Wu L, Zhang Y, Sheng X, Yu Q, Sheng H, Xi B, Zhang JZ and Zang YQ: Liver X receptor (LXR) mediates negative regulation of mouse and human Th17 differentiation. J Clin Invest. 121:658–670. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Villablanca EJ, Raccosta L, Zhou D, Fontana R, Maggioni D, Negro A, Sanvito F, Ponzoni M, Valentinis B, Bregni M, et al: Tumor-mediated liver X receptor-alpha activation inhibits CC chemokine receptor-7 expression on dendritic cells and dampens antitumor responses. Nat Med. 16:98–105. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Feig JE, Pineda-Torra I, Sanson M, Bradley MN, Vengrenyuk Y, Bogunovic D, Gautier EL, Rubinstein D, Hong C, Liu J, et al: LXR promotes the maximal egress of monocyte-derived cells from mouse aortic plaques during atherosclerosis regression. J Clin Invest. 120:4415–4424. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Noghero A, Perino A, Seano G, Saglio E, Lo Sasso G, Veglio F, Primo L, Hirsch E, Bussolino F and Morello F: Liver X receptor activation reduces angiogenesis by impairing lipid raft localization and signaling of vascular endothelial growth factor receptor-2. Arterioscler Thromb Vasc Biol. 32:2280–2288. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Pencheva N, Buss CG, Posada J, Merghoub T and Tavazoie SF: Broad-spectrum therapeutic suppression of metastatic melanoma through nuclear hormone receptor activation. Cell. 156:986–1001. 2014. View Article : Google Scholar : PubMed/NCBI |
